Summary
| Herb Id: TCMCG009 | Herb name: Cannabis sativa |
| Function: To dispel wind, quicken blood, engender hairs. | Indication: Numbness in limbs, itchy body, shedding of eyebrow and hair, amenorrhea. |
Ingredient
| Ingredient_name: 3,7(11)-selinadiene | Alias: NA |
| Ingredient_formula: C15H24 | Ingredient_Smile: CC1=CCCC2(C1CC(=C(C)C)CC2)C |
| Ingredient_weight: 204.35 g/mol | OB_score: NA |
| PubChem_id: 6432648 | EC: 1.14.15.32 [VIEW IN KEGG] 4.2.3.7 [VIEW IN KEGG] 4.2.3.6 [VIEW IN KEGG] 4.2.3.13 [VIEW IN KEGG] |
| Ingredient_name: 7alpha,21S,25-Trihydroxy-3beta-acetoxy-21S,23R-epoxy-9(11)-en-dammarane | Alias: [(3S,8S,10S)-7-hydroxy-17-[(2S,5R)-2-hydroxy-5-(2-hydroxy-2-methylpropyl)oxolan-3-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; AC1NT14F; 7α,21s,25-trihydroxy-3β-acetoxy-21s,23r-epoxy-9(11)-en-dammarane; 7alpha,21s,25-trihydroxy-3beta-acetoxy-21s,23r-epoxy-9(11)-en-dammarane |
| Ingredient_formula: NA | Ingredient_Smile: CC(=O)OC1CCC2(C(C1(C)C)CC(C3(C2=CCC4C3(CCC4C5CC(OC5O)CC(C)(C)O)C)C)O)C |
| Ingredient_weight: 532.84 | OB_score: 10.94031937 |
| PubChem_id: NA | EC: - |
| Ingredient_name: alpha-Farnesene | Alias: alpha-farnesene; CHEBI:10280; 502-61-4; α-farnesene; (E,E)-alpha-Farnesene; (3E,6E)-3,7,11-trimethyldodeca-1,3,6,10-tetraene; C09665; α- farnesene; W383902_ALDRICH; nchembio.2007.29-comp7; 1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-; (E)-alpha-Farnesene; .alpha.-Farnesene; 3,7,11-trimethyldodeca-1,3,6,10-tetraene; CHEBI:39236 |
| Ingredient_formula: C15H24 | Ingredient_Smile: CC(=CCCC(=CCC=C(C)C=C)C)C |
| Ingredient_weight: 204.35 | OB_score: 21.70351121 |
| PubChem_id: 5281516 | EC: 1.14.15.32 [VIEW IN KEGG] 4.2.3.7 [VIEW IN KEGG] 4.2.3.6 [VIEW IN KEGG] 4.2.3.13 [VIEW IN KEGG] |
| Ingredient_name: cannabidiol | Alias: abn-cbd, (-)-4-(3-3,4-trans-p-menthadien-[1,8]-yl)olivetol; SCHEMBL16224872 |
| Ingredient_formula: C21H30O2 | Ingredient_Smile: CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O |
| Ingredient_weight: 314.5 g/mol | OB_score: 3.967290479 |
| PubChem_id: 644019 | EC: 1.1.1.145 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] 1.14.13.54 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.15.4 [VIEW IN KEGG] 1.14.15.8 [VIEW IN KEGG] 1.14.99.4 [VIEW IN KEGG] 1.14.99.14 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 4.2.1.98 [VIEW IN KEGG] |
| Ingredient_name: cannabidiolic acid | Alias: cannabidiolicacid; 2,4-dihydroxy-3-[(6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-6-pentylbenzoate; CBDA |
| Ingredient_formula: C8H4O6 | Ingredient_Smile: C12C(C3C1C(=O)OC3=O)C(=O)OC2=O |
| Ingredient_weight: 196.11 g/mol | OB_score: NA |
| PubChem_id: 107280 | EC: - |
| Ingredient_name: cannabigerol | Alias: NA |
| Ingredient_formula: C21H32O2 | Ingredient_Smile: CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O |
| Ingredient_weight: 316.48 | OB_score: NA |
| PubChem_id: 5315659 | EC: 1.1.1.145 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.14.29 [VIEW IN KEGG] 1.14.15.6 [VIEW IN KEGG] 2.8.2.2 [VIEW IN KEGG] 2.8.2.14 [VIEW IN KEGG] 3.1.6.2 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.1.1.213 [VIEW IN KEGG] 1.1.1.278 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.1.1.50 [VIEW IN KEGG] 1.1.1.277 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] |
| Ingredient_name: Cannabinol | Alias: 521-35-7; NINDS_000972; Cannabinolum [INN-Latin]; Tox21_113486; 3-Amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; NCGC00168261-01; Cannabinol [BAN:INN]; Cannabinol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; 6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; DSSTox_RID_83188; CAS-521-35-7; CHEBI:3360; Cannabinol [INN:BAN]; cannabinol; Cannabinolum; C07580; Cannabinol (6CI); Cannabinol, analytical standard; Cannabinol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis; 6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl- (7CI,8CI,9CI); D0U5LL; CHEMBL74415; KBio1_000972; 6,6,9-Trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol. Product derived from Cannabis sativa; 6,6,9-Trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol #; 6H-Dibenzo[b, 6,6,9-trimethyl-3-pentyl-; HMS503C05; 6,6,9-Trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; 5-17-04-00567 (Beilstein Handbook Reference); IDI1_000972; Cannabinol solution; ZINC1530833; C6520_SIGMA; DSSTox_CID_28922; C6888_SIGMA; NSC 134455; WLN: T B666 HO IHJ CQ E5 I1 I1 M1; DivK1c_000972; DTXSID3048996; Cannabinolo [DCIT]; AC1L1DWZ; L000158; UNII-7UYP6MC9GH; Cannabinolo; 7UYP6MC9GH; 6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-pentyl-; VBGLYOIFKLUMQG-UHFFFAOYSA-N; LMPK13120002; 3-amyl-6,6,9-trimethyl-benzo[c]chromen-1-ol; BRN 0237145; NSC-134455; GTPL740; 6,6,9-Trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol(Cannabinol); FT-0664223; 6,6,9-trimethyl-3-pentyl-1-benzo[c]chromenol; 6,6,9-Trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol (Cannabinol); SCHEMBL121085; 6,6,9-Trimethyl-3-pentyl-6H-benzo[c]chromen-1-ol; Cannabinol 1.0 mg/ml in Methanol; DSSTox_GSID_48996; 6,6,9-trimethyl-3-pentyl-benzo[c]chromen-1-ol; 6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol; NSC134455; 3-Amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo(b,d)pyran; BDBM50061117; AKOS024457448; 6H-Dibenzo(b,d)pyran-1-ol, 6,6,9-trimethyl-3-pentyl-; LMPK02000025; LS-61184; 3-Amyl-1-hydroxy-6,9-trimethyl-6H-dibenzo[b,d]pyran; 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| Ingredient_formula: C21H26O2 | Ingredient_Smile: CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O |
| Ingredient_weight: 310.43 | OB_score: 22.03738201 |
| PubChem_id: 2543 | EC: - |
| Ingredient_name: cannabinolic acid | Alias: Cannabinolic acid; CTK1A7709; DTXSID60182356; CHEMBL464869; 6H-Dibenzo(b,d)pyran-2-carboxylic acid, 1-hydroxy-6,6,9-trimethyl-3-pentyl-; CBNA; 2808-39-1; cannabinolic acid A; AC1MIXY1; 6H-Dibenzo[b,d]pyran-2-carboxylicacid, 1-hydroxy-6,6,9-trimethyl-3-pentyl-; SCHEMBL13120592; cannabinolicacid; 1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid |
| Ingredient_formula: C22H26O4 | Ingredient_Smile: CCCCCC1=CC2=C(C3=C(C=CC(=C3)C)C(O2)(C)C)C(=C1C(=O)O)O |
| Ingredient_weight: 354.4 g/mol | OB_score: NA |
| PubChem_id: 3081990 | EC: - |
| Ingredient_name: delta2-tetrahydrocannabinolic acid | Alias: NA |
| Ingredient_formula: NA | Ingredient_Smile: CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1C(=O)O)(C)C)C)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: - |
| Ingredient_name: delta(9)-tetrahydrocannabinol | Alias: 5957-27-7; (6aS,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; delta(9)-THC; L-.delta.1-trans-Tetrahydrocannabinol; Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; 6H-Dibenzo[b,d]pyran-1-ol,6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; (6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-; Compassia; L-delta1-trans-Tetrahydrocannabinol; US9416103, Delta9-THC; (-)-delta9-Tetrahydrocannabinol; delta(sup9)-Thc; delta(sup 9)-Tetrahydrocannabinol; C06972; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; CHEMBL465; L-delta(sup 1)-tetrahydrocannabinol; 23623-EP2298772A1; D00306; (-)-.DELTA.9-Tetrahydrocannabinol; Dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a U.S. FDA approved drug product; (6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; .DELTA.1-Tetrahydrocannabinol; delta 9-Tetrahydrocannabinol; delta-9-THC; Delta9-Tetrahydrocannabinol solution, ethanol solution; Marinol; Cannabinol, tetrahydro- (6CI); 6465-30-1; 124699-EP2272825A2; delta9-THC; delta(1)-THC; SP 104; DEA No. 7370; 23623-EP2314298A1; DRG-0138; Dronabinol [USAN:USP:INN]; 3ls4; (l)-delta1-Tetrahydrocannabinol; Delta9-Tetrahydrocannabinol solution; Syndros; delta(9)-Tetrahydrocannibinol; (-)-Delta9-THC (Dronabinol) 1.0 mg/ml in Methanol; DSSTox_RID_76083; BIDD:GT0427; THC; 23623-EP2275420A1; 124699-EP2289509A2; Tetranabinex; delta-9 Tetrahydrocannabinol; Synthetic THC in sesame oil / soft gelatin; (-)-trans-Delta9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; CYQFCXCEBYINGO-IAGOWNOFSA-N; 1-trans-delta(sup9)-tetrahydrocannabinol; Dronabinol in sesame oil in soft gelatin capsule; THC-delta-9; (-)-delta9-trans-Tetrahydrocannabinol; BDBM50007391; CHEBI:66964; (-)-trans-Delta1-Tetrahydrocannabinol; QCD-84924; 6H-Dibenzo; HSDB 6471; (10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; 14146-29-3; (-)-trans-delta9-Tetrahydrocannabinol; Cannabinol, .DELTA.1-tetrahydro-; trans-.DELTA.9-Tetrahydrocannabinol; CCRIS 4726; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-; .delta.(sup9)-THC; Marinol (TN); Deltanyne; (-)-Delta9-Tetrahydrocannabinol solution; (-)-Delta9-THC (Dronabinol) 5.0 mg/ml in Methanol; delta9-trans-Tetrahydrocannabinol; 6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol; trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; AC1L277U; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; 23623-EP2308839A1; 23623-EP2314580A1; (L)-.delta.1-Tetrahydrocannabinol; CAT-310; 6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol; (-)-(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; trans-tetrahydrocannabinol; Cannabinol, delta1-tetrahydro-; 23623-EP2298764A1; (-)-Delta9-Tetrahydrocannabinol solution, ~1 mg/mL in ethanol, analytical standard, for drug analysis; 1363-19-5; (l)-delta(sup 1)-Tetrahydrocannabinol; AC1Q2VRZ; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; Relivar; (-)-.DELTA.9-THC; D0P1FO; delta(sup 1)-Tetrahydrocannabinol; SCHEMBL4609; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; .delta.-9-THC; delta9-Tetrahydrocannabinol; Epitope ID:224552; PDSP2_000714; Namisol; 14146-43-1; UNII-7J8897W37S; (-)-trans-.DELTA.9-Tetrahydrocannabinol; Abbott 40566; INT-0010/06; 23623-EP2269989A1; DEA No. 7369; (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; LS-975; delta(sup 9)-Thc; Ganja; 1972/8/3; Cannabis resin; Dronabinol (USP/INN); 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(DeltaE-9-THC); 9-delta-Tetrahydrocannabinol; 124699-EP2295427A1; 148820-EP2289509A2; 1-trans-D9-Tetrahydrocannabinol; CTK8D8346; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; 9-tetrahydrocannabinol; Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; NSC 134454; 3-pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol; (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; ZINC1530625; INT-0010; .DELTA.9-trans-Tetrahydrocannabinol; delta(9)-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol (VAN); (-)-.DELTA.1-Tetrahydrocannabinol; Hashish; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-; 1-trans-delta(sup 9)-Tetrahydrocannabinol; DTXSID6021327; L-.delta.1-Tetrahydrocannabinol; 1-trans-delta-9-Tetrahydrocannabinol; (-)-delta9-(trans)-Tetrahydrocannabinol; Drona binol; BDBM60994; (-)-delta1-Tetrahydrocannabinol; L-trans-delta9-Tetrahydrocannabinol; delta(1)-Tetrahydrocannabinol; 8,8-Dimethyl-11-methylene-5-pentyl-3,4,8a,9,10,11,12,12a-octahydro-2H,8H-1,7-dioxa-benzo[c]phenanthrene; Dronabinolum [Latin]; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-; Dronabinol [USAN:INN]; API0002497; TETRAHYDROCANNABINOL; Tetrahydrocannabinol delta9; (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol; 9-THC; Cannabinol, 1-trans-delta(sup 9)-tetrahydro-; 26108-45-2; 9-ene-Tetrahydrocannabinol; 6H-Dibe nzo[b,d]pyran-1-ol,6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-3-pentyl-6,6,9-trimethyl- (6ar-trans)-; trans-delta9-Tetrahydrocannabinol; Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-di benzo[b,d]pyran-1-ol; Delta-9-Tetrahydrocannabinol, United States Pharmacopeia (USP) Reference Standard; (-)-.delta.(sup9)-trans-Tetrahydrocannabinol; QCD 84924; 14C-.DELTA.1-Tetrahydrocannabinol; (-)-.DELTA.9-trans-Tetrahydrocannabinol; Tox21_112616; DSSTox_CID_1327; Cannabinol, Delta1-tetrahydro-(7CI); (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol(l)-delta(sup 1)-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol; Dronabinol; trans-delta-9-Tetrahydrocannabinol; .DELTA.9-THC; NSC-134454; 124699-EP2295426A1; 7J8897W37S; (-)-Delta9-THC (Dronabinol) 0.1 mg/ml in Methanol; NSC134454; CAS-1972-08-3; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; 6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-; (6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO[C]ISOCHROMEN-1-OL; Dronabinolum; .DELTA.9-Tetrahydrocannabinol; 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; Cannabinol, Delta1-tetrahydro- (7CI); 6H-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-; L-trans-.delta.9-Tetrahydrocannabinol; delta9-Tetrahydrocannabinol (VAN); D0L4AI; 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(delta9-THC(delta9-tetrahydrocannabinol)); Cannabinol, tetrahydro-(6CI); delta-9-tetrahydrocannabinol; delta1-THC; 23623-EP2298765A1; (S)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; (-)-trans-Delta9-THC; .DELTA.1-THC; Delta9-Tetrahydrocannabinol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis; GTPL2424; 1-trans-delta9-Tetrahydrocannabinol; 1-trans-.delta.(sup9)-tetrahydrocannabinol; DB00470; DSSTox_GSID_21327; delta-THC; delta(sup 1)-Thc; 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol |
| Ingredient_formula: C21H30O2 | Ingredient_Smile: CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O |
| Ingredient_weight: 314.5 g/mol | OB_score: NA |
| PubChem_id: 16078 | EC: 1.1.1.145 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] 1.14.13.54 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.15.4 [VIEW IN KEGG] 1.14.15.8 [VIEW IN KEGG] 1.14.99.4 [VIEW IN KEGG] 1.14.99.14 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 4.2.1.98 [VIEW IN KEGG] |
| Ingredient_name: eugenol | Alias: EINECS 202-589-1; D0O4QB; Eugenol, tested according to Ph.Eur.; SCHEMBL20361; NCGC00091449-08; Eugenol, primary pharmaceutical reference standard; 1,3,4-Eugenol; Spectrum4_001783; AIDS002235; EPA Pesticide Chemical Code 102701; NSC8895; Engenol; BC682398; MolPort-001-783-095; SBB012362; IDI1_000692; 2-Methoxy-4-(2-propen-1-yl)phenol; ACMC-1AOH6; Tox21_300105; BDBM50164168; BIDD:ER0696; Phenol, 2-methoxy-4-(2-propenyl)-; Eugenol [USP]; NSC-8895; ST069318; 3s0e; STL371304; Eugenol, certified reference material, TraceCERT(R); AIDS-002235; BRN 1366759; DB09086; 2-Methoxy-4-allylphenol; FEMA No. 2467; KSC486Q8H; 1-allyl-4-hydroxy-3-methoxybenzene; SR-05000002043-1; Allylguaiacol; 2-methoxy-4-(prop-2-en-1-yl)phenol; MLS000028901; HMS502C14; Eugenol, Pharmaceutical Secondary Standard; Certified Reference Material; NCGC00091449-04; 4-allyl-2-methoxy-phenol; Spectrum5_000425; NSC-757030; SBI-0051381.P003; NSC757030; NCGC00091449-05; Caryophyllic ac id; Pharmakon1600-01500296; NCGC00091449-01; E51791_ALDRICH; BSPBio_002251; NCGC00259589-01; I01-8770; CTK3I6883; Phenol, 2-methoxy-4-(2-propen-1-yl)-; CCG-38827; 1-Hydroxy-2-methoxy-4-allylbenzene; InChI=1/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H; Spectrum3_000646; NCGC00091449-02; ANW-40868; BG00601193; 1-Allyl-3-methoxy-4-hydroxybenzene; Caryophyllic acid; Eugenol, 99% 100g; NINDS_000692; 4-Hydroxy-3-methoxyallylbenzene; CS-7807; 1-hydroxy-2-methoxy-4-propenylbenze ne; Eugenol, ReagentPlus(R), 99%; 4-(2-Propenyl)-2-methoxyphenol; NCGC00091449-07; 1-hydroxy-4-allyl-2-methoxybenzene; Eugenol, Vetec(TM) reagent grade, 98%; 2-methoxy-4-(prop-2-en-1-yl)phenol4-allyl-2-methoxyphenol; FS-2702; HSDB 210; MFCD00008654; KS-00000WP5; 4 -allyl-1-hydroxy-2-methoxybenzene; 4-Allylguaiacol; bmse010053; LS-2027; RRAFCDWBNXTKKO-UHFFFAOYSA-N; Eugenol [USAN]; NCGC00253915-01; CAS-97-53-0; Eugenol, natural, >=98%, FG; Tox21_111134; EOL; W246700_ALDRICH; DSSTox_GSID_20617; AK307784; AKOS000121354; C10453; FA 100; 35995_RIEDEL; Q-201105; NCGC00091449-06; AI3-00086; NCI-C50453; HY-N0337; CJ-00049; FEMA Number 2467; s4706; 4-Hydroxy-3-methoxy-1-allylbenzene; CCRIS 306; NSC209525; NSC-209525; ZINC00001411; Eugenol; DSSTox_CID_617; 46100_FLUKA; Synthetic eugenol; Eugenolum; 97-53-0; AC1L1FNK; SDCCGMLS-0066578.P001; 4-Allyl-1-Hydroxy-2-Methoxy Benzene; SPECTRUM1500296; AC1Q46B0; 46129_FLUKA; N1805; KBio1_000692; TR-038621; EC 202-589-1; Eugenol, United States Pharmacopeia (USP) Reference Standard; 4-Allylcatechol-2-methyl ether; 4-Allylcatechol 2-methyl ether; SMR000059114; 2-Methoxy-4-[2-propenyl]phenol; 2-methoxy-4-prop-2-enyl-phenol; Eugenol (natural); SR-05000002043; Eugenol, >=98%, FCC, FG; FT-0615974; 4-allyl-2methoxyphenol; ZINC1411; Eugenic acid; Bio-0581; Eugenol (USP); D04117; Eugenol Special; DivK1c_000692; CHEMBL42710; dentogum; KBio3_001471; Eugenol, puriss., 98%; NCGC00091449-03; 2-Methoxy-4-(2-propenyl)phenol; CHEBI:4917; AB00051992_02; 2-Methoxy-4-(3-propenyl)phenol; BBL027721; 4-Allylguaicol; 2-Hydroxy-5-allylanisole; p-Eugenol; NCGC00091449-10; KB-51837; Caswell No. 456BC; eugenol ; 2-Methoxy-4-prop-2-enylphenol; 2-Metoksy-4-allilofenol [Polish]; Tox21_202040; 3T8H1794QW; KBioGR_002327; 2-Methoxy-1-hydroxy-4-allylbenzene; K753; Spectrum2_001264; 3-(3-methoxy-4-hydroxyphenyl)propene; DSSTox_RID_75693; WLN: 1U2R DQ CO1; F0001-2306; I01-7260; GTPL2425; 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene; 5-Allylguaiacol; 2-Metoksy-4-allilofenol; Eugenol, European Pharmacopoeia (EP) Reference Standard; UNII-3T8H1794QW; p-Allylguaiacol; NSC 209525; 4-Allyl-1-hydroxy-2-methoxybenzene; 4-Allyl-2-methoxyphenol; BRD-K32977963-001-01-9; W246719_ALDRICH; RTR-038621; HMS2091F09; Tox21_111134_1; A0232; Phenol, 4-allyl-2-methoxy-; HMS1920O08; SR-05000002043-2; SPBio_001228; DTXSID9020617; bioxeda; Epitope ID:114091; Eugenol, PESTANAL(R), analytical standard; AC1Q7AE5; 4-allyl-2-methoxy-Phenol |
| Ingredient_formula: C10H12O2 | Ingredient_Smile: COC1=C(C=CC(=C1)CC=C)O |
| Ingredient_weight: 164.2 | OB_score: 56.24190209 |
| PubChem_id: 3314 | EC: 1.2.1.29 [VIEW IN KEGG] 1.14.12.25 [VIEW IN KEGG] 1.1.1.318 [VIEW IN KEGG] 2.1.1.146 [VIEW IN KEGG] 1.1.1.319 [VIEW IN KEGG] 1.13.11.88 [VIEW IN KEGG] 2.1.1.279 [VIEW IN KEGG] |
| Ingredient_name: eugenol methyl ether | Alias: SCHEMBL219169 |
| Ingredient_formula: C11H14O2 | Ingredient_Smile: COC1=C(C=C(C=C1)CC=C)OC |
| Ingredient_weight: 178.23 g/mol | OB_score: NA |
| PubChem_id: 7127 | EC: 2.1.1.146 [VIEW IN KEGG] 2.1.1.279 [VIEW IN KEGG] |
| Ingredient_name: linalyl oxide | Alias: Linalyl oxide; Linalool oxide, cis-furanoid; cis-2-Methyl-2-vinyl-5-(1-hydroxy-1-methylethyl)tetrahydrofuran; Linalool oxide, natural, >=95%; FEMA 3746; cis-Linalool oxide (furanoid form); 2-Methyl-2-vinyl-5-(1-hydroxy-1-methylethyl)tetrahydrofuran; cis-linalool oxide (furanoid); Z-Furanoid linalool oxide; AN-21150; 2-ETHENYL-2-METHYL-5-(1-METHYL-1-HYDROXY)ETHYLTETRAHYDROFURAN; 2,6-Dimethyl-3,6-oxido-7-octen-2-ol; 2-(5-Methyl-5-vinyltetrahydro-2-furyl)-2-propanol; Z-2-Ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-furanmethanol; BRHDDEIRQPDPMG-UHFFFAOYSA-N; Tetrahydro-2-methyl-5-(1-hydroxy-1-methylethyl)-2-vinylfuran; 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-; 2-(5-methyl-5-vinyl-tetrahydrofuran-2-yl)propan-2-ol; cis-Linalool oxide (furanyl ring); cis-Linalool-3,6-oxide; CHEBI:88534; 2-Furanmethanol,.alpha.,5-trimethyl-; Linalool oxide I (cis, furanoid); 2-Furanmethanol, 5-ethenyltetrahydro-alpha,alpha,5-trimethyl-; Linalool oxide, cis; (Z)-Furan linalool oxide; 5-Ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-cis-2-furanmethanol; CTK3J2733; RTR-037230; alpha,alpha,5-Trimethyl-5-vinyltetrahydrofurfuryl alcohol; Furan linalool oxide; 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-, (2R,5S)-rel-; 5-Ethenyltetrahydro-alpha,alpha,5-trimethyl-2-furanmethanol; (Z)-Linalool oxide, furanoid; Linalool oxide, mixture of isomers, >=97.0% (GC); cis-Linalol oxide (furan isomer); 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-, cis-; 2-(5-Methyl-5-vinyltetrahydro-2-furanyl)-2-propanol #; 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-, trans-; 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-, (2R,5R)-rel-; Linalool 3,6-oxide; 34995-77-2; cis-Linalool furan oxide; 2-(Tetrahydro-5-methyl-5-vinyl-2-furyl)propan-2-ol; Linalool oxide B; BRN 0117527; 2,6-Dimethyl-3,6-oxido-7-oxten-2-ol; NE11074; 5-17-03-00253 (Beilstein Handbook Reference); 2-((2R,5S)-5-Methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; cis-Furan linalool oxide; LS-2881; I14-56452; AC1L2K58; L0143; 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol; 2-(5-Methyl-5-vinyltetrahydro-2-furanyl)-2-propanol; Furfuryl alcohol, tetrahydro-.alpha.,.alpha.,5-trimethyl-5-vinyl-, cis-; (Z)-Linalool furanoxide; trans-5-Ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-2-furanmethanol; cis-Linalool oxide (furan type); Z-linalool oxide (furan); Epoxylinalool; cis-Furanic linalool oxid; NSC93936; 5989-33-3; 2-(5-Methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; (Z)-Linalool oxide (furanoid); 2-Methyl-2-vinyl-5-(2-hydroxy-2-propyl)tetrahydrofuran; (Z)-Linalool oxide B; TR-037230; linalool oxide (furanoid); EINECS 262-038-6; cis-Linalool Oxide; SCHEMBL295274; (Z)-Linalool oxyde (furanoid); Linalool oxide (cis-furanoid); Linalool oxide B ((Z)-furanoid); Linalool oxide, (Z)-; cis-5-Ethenyltetrahydro-.alpha.,.alpha.,5-Trimethyl-2-furanmethanol; 60047-17-8; Linolool oxide; cis-Linalol furanoxide; 2-(2-Hydroxy-2-propyl)-5-methyl-5-vinyltetrahydrofuran; Tetrahydro-alpha,alpha,5-trimethyl-5-vinylfuran-2-methanol; 5-Ethenyltetrahydro-a,a,5-trimethyl-2-furanmethanol, 9CI; 5-(1-Hydroxy-1-methylethyl)-2-methyl-2-vinyltetrahydrofuran; Furfuryl alcohol, tetrahydro-.alpha.,.alpha.,5-trimethyl-5-vinyl-; NSC-93936; cis-Linalool oxide furan; MolPort-004-964-112; linalooloxide; cis-Linalyl oxide (furanoid); cis-Linalyl Oxide |
| Ingredient_formula: C10H18O2 | Ingredient_Smile: CC1(CCC(O1)C(C)(C)O)C=C |
| Ingredient_weight: 170.25 g/mol | OB_score: NA |
| PubChem_id: 22310 | EC: 1.1.1.241 [VIEW IN KEGG] 1.14.14.133 [VIEW IN KEGG] 1.14.14.84 [VIEW IN KEGG] 1.1.1.297 [VIEW IN KEGG] 3.3.2.8 [VIEW IN KEGG] 1.1.1.324 [VIEW IN KEGG] 1.14.14.83 [VIEW IN KEGG] 1.14.13.105 [VIEW IN KEGG] 3.1.1.83 [VIEW IN KEGG] 1.14.14.56 [VIEW IN KEGG] 2.2.1.12 [VIEW IN KEGG] |
| Ingredient_name: linamarin | Alias: CHEBI:16441; 2-(beta-D-Glucopyranosyloxy)-2-methylpropionitrile; SR-05000002494-1; CTK8G0586; BSPBio_003283; KBioSS_002500; BICL4127; SCHEMBL42021; FT-0608720; KBio2_007628; 1-cyano-1-methylethyl beta-D-glucoside; KBio3_002503; C01594; Spectrum_001946; SpecPlus_000936; Spectrum3_001622; CCG-39428; 2-beta-d-glucopyranosyloxy-2-methylpropanenitrile; CHEMBL3039425; 2-(; LINAMARIN; SPBio_002123; KBio1_001976; W-203090; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside, >=98.0% (HPLC); Propanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl-; NCGC00178164-01; 2-Methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanenitrile; 5-17-07-00397 (Beilstein Handbook Reference); AKOS030242445; MFCD00036209; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-propanenitrile; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside; Linamarin; LS-120874; Spectrum5_000575; DTXSID8052857; Manihotoxin; KBio2_005060; SR-05000002494; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-propionitrile; KBio2_002492; H3V9RP3WLO; UNII-H3V9RP3WLO; BRN 0019237; 2-(beta-D-Glucopyranosyloxy)-2-methyl-Propanenitrile; DivK1c_007032; 2-(beta-D-Glucopyranosyloxy)-2-methylpropanenitrile; HSDB 3507; alpha-Hydroxyisobutyronitrile-beta-D-glucose; 2-(beta-D-Glucopyranosyloxy)isobutyronitrile; A-D-Glucopyranosyloxy)-2-methyl-propanenitrile; Spectrum2_001972; alpha-Hydroxyisobutyronitrile beta-D-glucose; 2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]propanenitrile; C-51988; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-propanenitrile; MolPort-003-665-717; A-D-Glucopyranosyloxy)-2-methylpropionitrile; ZINC3984017; Phaseolunatin; KBioGR_002195; 2-(b-D-Glucopyranosyloxy)-2-methylpropanenitrile, 9CI; SPECTRUM1504124; SDCCGMLS-0066829.P001; 2-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanenitrile; Spectrum4_001668; AC1L1WOH; 554-35-8; AK600739; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanenitrile |
| Ingredient_formula: C10H17NO6 | Ingredient_Smile: CC(C)(C#N)OC1C(C(C(C(O1)CO)O)O)O |
| Ingredient_weight: 247.24 g/mol | OB_score: NA |
| PubChem_id: 11128 | EC: 2.4.1.63 [VIEW IN KEGG] 3.2.1.21 [VIEW IN KEGG] |
| Ingredient_name: muscarine i | Alias: NA |
| Ingredient_formula: C9H20NO2+ | Ingredient_Smile: CC1C(CC(O1)C[N+](C)(C)C)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: - |
| Ingredient_name: muscarine(ii) | Alias: NA |
| Ingredient_formula: C9H20NO2+ | Ingredient_Smile: CC1C(CC(O1)C[N+](C)(C)C)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: - |
| Ingredient_name: piperidine | Alias: BG00956967; BCP0726000204; AN-3762; DTXSID30705359; (7bR,10aR)-2,3,4,7B,8,9,10,10a-Octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-hi]indolehydrochloride; CO-124; AX8163273; (11R,15R)-7,10-DIAZATETRACYCLO[8.5.1.0?,(1)?.0(1)(1),(1)?]HEXADECA-1(16),2,4-TRIENE HYDROCHLORIDE; WAY163909-HCl; (7BR,10AR)-2,3,4,7B,8,9,10,10A-OCTAHYDRO-1H-CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1-HI]INDOLE HYDROCHLORIDE; AKOS016002206; 428868-35-3; PS-J-141; AK-38565; (7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole--hydrogen chloride (1/1); (11R,15R)-7,10-DIAZATETRACYCLO[8.5.1.0?,(1)?.0(1)(1),(1)?]HEXADECA-1,3,5(16)-TRIENE HYDROCHLORIDE; KB-277464; (7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole hydrochloride; (7BR,10AR)-2,3,4,7B,8,9,10,10A-Octahydro-1H-cyclopenta[b][1,4diazepino][6,7,1-HI]indole hydrochloride |
| Ingredient_formula: C5H11N | Ingredient_Smile: C1CCNCC1 |
| Ingredient_weight: 85.15 g/mol | OB_score: NA |
| PubChem_id: 8082 | EC: 2.3.1.145 [VIEW IN KEGG] 1.5.1.48 [VIEW IN KEGG] |
| Ingredient_name: piperine | Alias: KBio2_003371; AIDS024972; SPBio_002547; ZINC01529772; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (E,E)-; 1-[5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]piperidine; DivK1c_000954; NSC242267; CCRIS 5572; 1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine, (E,E)-; P49007_ALDRICH; BSPBio_000608; 7780-20-3; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; 1-[5-(3,4-pentadienyl]piperidine; Piperin; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)-; Piperine (aliphatic); piperine ; SCHEMBL14171509; Spectrum2_000049; KBioSS_000803; 1-PIPEROYL-(E,E)-PIPERIDINE; ZINC5945454; IDI1_000954; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (Z,E)-; NCGC00094872-03; Prestwick1_000474; 1-Piperoyl-piperidine; InChI=1/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3; NCGC00094872-01; Piperidine, 1-piperoyl-, (E,E)-; Piperidine, 1-[5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; SR-01000638580-1; Piperidine,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; UNII-Z3C7H03C5M; KBio1_000954; BPBio1_000670; N-[(E,E)-piperoyl]-piperidine; 1-Piperoylpiperidine; Piperidine, 1-(5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)-; 5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NCGC00094872-02; Z3C7H03C5M; (2Z,4E)-5-(2H-1,3-BENZODIOXOL-5-YL)-1-(PIPERIDIN-1-YL)PENTA-2,4-DIEN-1-ONE; piperidine, 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; NSC21727; 1-(5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)piperidine; Spectrum_000323; (2Z,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1,3-Benzodioxol-5-yl-1-oxo-2,4-pentadienyl-piperine; (E,E) 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)- (9CI); Spectrum4_000708; 1-Piperoylpiperidine, (E,E)-; KBio3_002015; Prestwick3_000474; AIDS-024972; Spectrum3_000868; KBio2_005939; Prestwick_398; Prestwick0_000474; Prestwick2_000474; Piperidine, 1-((2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (E,E)-1-piperoylpiperidine; FEMA No. 2909; SPBio_000177; C03882; 147030-08-8; N-[(E,E)-Piperoyl]piperidine; 80810_FLUKA; Piperoylpiperidine; 5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Spectrum5_001507; 94-62-2; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; W290904_ALDRICH; NINDS_000954; BSPBio_002515; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-2,4-pentadienoyl]piperidine; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoyl]piperidine; Piperine; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; Piperidine,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; KBioGR_001235; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NSC 242267; AC1LU7IP; SDCCGMLS-0066693.P001; AI3-01439; NSC 21727; Isopiperine; KBio2_000803; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; CHEBI:28821; ST5307921; 30511-76-3; NSC-242267; SPECTRUM1500873; EINECS 202-348-0 |
| Ingredient_formula: C17H19NO3 | Ingredient_Smile: C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 |
| Ingredient_weight: 285.34 | OB_score: 42.51674418 |
| PubChem_id: 638024 | EC: 1.1.1.218 [VIEW IN KEGG] 1.1.1.247 [VIEW IN KEGG] 1.14.11.32 [VIEW IN KEGG] 1.14.14.1 [VIEW IN KEGG] 2.4.1.17 [VIEW IN KEGG] 2.3.1.145 [VIEW IN KEGG] 1.14.19.66 [VIEW IN KEGG] 2.1.1.115 [VIEW IN KEGG] 2.1.1.128 [VIEW IN KEGG] 2.1.1.140 [VIEW IN KEGG] |
| Ingredient_name: selina-4(15),7(11)-diene | Alias: NA |
| Ingredient_formula: C15H24 | Ingredient_Smile: CC(=C1CCC2(CCCC(=C)C2C1)C)C |
| Ingredient_weight: 204.35 g/mol | OB_score: NA |
| PubChem_id: 10655819 | EC: 1.14.15.32 [VIEW IN KEGG] 4.2.3.7 [VIEW IN KEGG] 4.2.3.6 [VIEW IN KEGG] 4.2.3.13 [VIEW IN KEGG] |
| Ingredient_name: tetrahydrocannabinol | Alias: 5957-27-7; L-.delta.1-trans-Tetrahydrocannabinol; 6,6,9-trimethyl-3-pentyl-1,2,3,4-tetrahydrobenzo[c]chromen-1-ol; (6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; (6aR,10aR)-3-amyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol; Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-; Compassia; AC1LAVZ6; 1972-08-3; C06972; delta(sup 9)-Tetrahydrocannabinol; D00306; (-)-.DELTA.9-Tetrahydrocannabinol; (-)-trans-Delta9-Tetrahydrocannabinol; Dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a U.S. FDA approved drug product; 6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; .DELTA.1-Tetrahydrocannabinol; T4764_SIGMA; Marinol; Cannabinol, tetrahydro- (6CI); 6465-30-1; delta9-THC; DEA No. 7370; SP 104; Delta9-trans-Tetrahydrocannabinol; DRG-0138; (-)-Delta9-Tetrahydrocannabinol; Delta9-Tetrahydrocannabinol solution; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol; delta(9)-Tetrahydrocannibinol; THC; delta(sup 1)-Thc; Tetranabinex; (-)-delta9-trans-Tetrahydrocannabinol; SCHEMBL5333795; (-)-trans-Delta1-Tetrahydrocannabinol; QCD-84924; HSDB 6471; 14146-29-3; Cannabinol, .DELTA.1-tetrahydro-; 1-trans-delta(sup9)-Tetrahydrocannabinol; trans-.DELTA.9-Tetrahydrocannabinol; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-; CCRIS 4726; .delta.(sup9)-THC; Marinol (TN); Deltanyne; trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; (-)-3,4-trans-Delta1-Tetrahydrocannabinol; (L)-.delta.1-Tetrahydrocannabinol; 1363-19-5; Cannabinol, delta1-tetrahydro-; (l)-delta(sup 1)-Tetrahydrocannabinol; Tetrahydrocannabinols (-)-delta1-3,4-trans-form; (-)-.DELTA.9-THC; delta(sup 1)-Tetrahydrocannabinol; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol; .delta.-9-THC; delta9-Tetrahydrocannabinol; PDSP2_000714; 14146-43-1; T2386_SIGMA; (-)-trans-.DELTA.9-Tetrahydrocannabinol; InChI=1/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H; Abbott 40566; DEA No. 7369; (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; delta(sup 9)-Thc; SJQJFSCMYCROHP-UHFFFAOYSA-N; Tetrahydrocannabinols; Dronabinol (USP/INN); l-delta1-trans-Tetrahydrocannabinol; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol; Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol; 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; (l)-Delta1-Tetrahydrocannabinol; NSC 134454; .DELTA.9-trans-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol (VAN); (-)-.DELTA.1-Tetrahydrocannabinol; 1-trans-delta(sup 9)-Tetrahydrocannabinol; (-)-delta9-(trans)-Tetrahydrocannabinol; 1-trans-delta-9-Tetrahydrocannabinol; L-.delta.1-Tetrahydrocannabinol; trans-Delta9-Tetrahydrocannabinol; Dronabinolum [Latin]; Dronabinol [USAN:INN]; Tetrahydrocannabinol delta9; (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol; 26108-45-2; Cannabinol, 1-trans-delta(sup 9)-tetrahydro-; (-)-.delta.(sup9)-trans-Tetrahydrocannabinol; QCD 84924; (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol(l)-delta(sup 1)-Tetrahydrocannabinol; (-)-.DELTA.9-trans-Tetrahydrocannabinol; 14C-.DELTA.1-Tetrahydrocannabinol; delta1-Tetrahydrocannabinol; Dronabinol; .DELTA.9-THC; 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-; 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-; NSC134454; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-; LMPK02000021; 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol; Cannabinol, Delta1-tetrahydro- (7CI); 6H-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-; L-trans-.delta.9-Tetrahydrocannabinol; l-trans-Delta9-Tetrahydrocannabinol; delta9-Tetrahydrocannabinol (VAN); delta1-THC; (-)-trans-Delta9-THC; .DELTA.1-THC; 1-trans-delta9-Tetrahydrocannabinol; 1-trans-.delta.(sup9)-tetrahydrocannabinol; (-)-Delta1-Tetrahydrocannabinol; 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans- |
| Ingredient_formula: C21H30O2 | Ingredient_Smile: CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O |
| Ingredient_weight: 314.46 | OB_score: 13.64834525 |
| PubChem_id: 16078 | EC: 1.1.1.145 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] 1.14.13.54 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.15.4 [VIEW IN KEGG] 1.14.15.8 [VIEW IN KEGG] 1.14.99.4 [VIEW IN KEGG] 1.14.99.14 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 4.2.1.98 [VIEW IN KEGG] |
| Ingredient_name: tetrahydrocannabinol delta5 | Alias: NA |
| Ingredient_formula: C21H30O2 | Ingredient_Smile: CCCCCC1=CC2=C(C3CC(C=CC3C(O2)(C)C)C)C(=C1)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: 1.1.1.145 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] 1.14.13.54 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.15.4 [VIEW IN KEGG] 1.14.15.8 [VIEW IN KEGG] 1.14.99.4 [VIEW IN KEGG] 1.14.99.14 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 4.2.1.98 [VIEW IN KEGG] |
| Ingredient_name: trigonelline | Alias: Prestwick_70; N-Methylnicotinic acid betaine hydrochloride; 1-methyl-3-pyridin-1-iumcarboxylate hydrochloride; MFCD00077250; SCHEMBL468365; A833196; trigonelline ; trigonelline HCl; 1-methylpyridin-1-ium-3-carboxylate hydrochloride; AC1O4WFS; 1-Methylpyridinium-3-carboxylate hydrochloride; T-6500; CHEMBL489961 |
| Ingredient_formula: C7H7NO2 | Ingredient_Smile: C[N+]1=CC=CC(=C1)C(=O)[O-] |
| Ingredient_weight: 137.14 g/mol | OB_score: NA |
| PubChem_id: 5570 | EC: 1.7.1.17 [VIEW IN KEGG] 1.13.11.23 [VIEW IN KEGG] 1.14.12.1 [VIEW IN KEGG] 1.14.13.35 [VIEW IN KEGG] 1.14.14.8 [VIEW IN KEGG] 2.1.1.111 [VIEW IN KEGG] 2.1.1.277 [VIEW IN KEGG] 2.3.1.113 [VIEW IN KEGG] 2.3.1.144 [VIEW IN KEGG] 2.4.2.18 [VIEW IN KEGG] 3.5.1.9 [VIEW IN KEGG] 3.7.1.3 [VIEW IN KEGG] 3.7.1.13 [VIEW IN KEGG] 4.1.1.24 [VIEW IN KEGG] 4.1.3.27 [VIEW IN KEGG] 6.2.1.32 [VIEW IN KEGG] 6.3.2.40 [VIEW IN KEGG] 1.14.13.27 [VIEW IN KEGG] 1.14.99.68 [VIEW IN KEGG] 2.4.2.54 [VIEW IN KEGG] 2.5.1.15 [VIEW IN KEGG] 4.1.3.38 [VIEW IN KEGG] 2.1.1.7 [VIEW IN KEGG] |
| Ingredient_name: Δ8-tetrahydrocannabinol | Alias: NA |
| Ingredient_formula: C21H30O2 | Ingredient_Smile: CCCCCC1=CC2=C(C3CC(=CCC3C(O2)(C)C)C)C(=C1)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: 1.1.1.145 [VIEW IN KEGG] 1.1.1.149 [VIEW IN KEGG] 1.3.1.3 [VIEW IN KEGG] 1.3.1.22 [VIEW IN KEGG] 1.3.99.6 [VIEW IN KEGG] 1.14.13.54 [VIEW IN KEGG] 1.14.14.16 [VIEW IN KEGG] 1.14.14.19 [VIEW IN KEGG] 1.14.15.4 [VIEW IN KEGG] 1.14.15.8 [VIEW IN KEGG] 1.14.99.4 [VIEW IN KEGG] 1.14.99.14 [VIEW IN KEGG] 5.3.3.1 [VIEW IN KEGG] 4.2.1.98 [VIEW IN KEGG] |
| Ingredient_name: Δ9-tetrahydrocannabinol | Alias: NA |
| Ingredient_formula: NA | Ingredient_Smile: CCCCCC1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)O |
| Ingredient_weight: NA | OB_score: NA |
| PubChem_id: NA | EC: - |